Shi Chen
Associate Director, Oncology Biology Innovent Biologics
Seminars
Monday 12th October 2026
Highlighting DuetTx Platform & Discovery of First-in-Class Dual Payload ADCs Advancing to the Clinic
10:00 am
- Laying out innovation-led approach to novel ADC therapies leveraging dual payload and target design
- Assessing design rationale and differentiated advantages of proprietary DuetTx platform
- Introducing preclinical efficacy and safety profile of dual payload ADC assets as first-in-generation advancing to clinical development
